| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |